W. Brückl

Neoadjuvant Treatment with Weekly High-Dose 5-Fluorouracil as 24-Hour Infusion, Folinic Acid and Oxaliplatin in Patients with Primary Resectable Liver Metastases of Colorectal Cancer

A. Wein, Christian U. Riedel, W. Brückl et al. · Oncology · 2003 · 83 citations

Medicine, Oncology, Pharmacotherapy +17

Immunotherapeutic maintenance treatment with toll-like receptor 9 agonist lefitolimod in patients with extensive-stage small-cell lung cancer: results from the exploratory, controlled, randomized, international phase II IMPULSE study

Michael Thomas, Santiago Ponce-Aix, Alejandro Navarro et al. · Annals of Oncology · 2018 · 81 citations · Full text

Medicine, Oncology, Pharmacology +15

Durvalumab after definitive chemoradiotherapy in locally advanced unresectable non-small cell lung cancer (NSCLC): Real-world data on survival and safety from the German expanded-access program (EAP)

Martin Faehling, Christian Schumann, Petros Christopoulos et al. · Lung Cancer · 2020 · 75 citations

Medicine, Oncology, Radiation Oncology +15

Multiple primary malignancies: An epidemiological and pedigree analysis of 57 patients with at least three tumours

Birgit Bittorf, Susanne Merkel, W. Brückl et al. · European Journal of Surgical Oncology · 2001 · 64 citations

Veterinary Medicine, Oncology, Cancer Epidemiology +12

Transforming growth factor beta 1 dependent regulation of Tenascin-C in radiation impaired wound healing

Falk Wehrhan, Franz Rödel, Gerhard G. Grabenbauer et al. · Radiotherapy and Oncology · 2004 · 35 citations

Life Sciences, Cell Biology, Radiation Oncology +14